| Primary |
| Coronary Artery Disease |
28.6% |
| Pemphigoid |
23.8% |
| Hypertension |
9.5% |
| Osteoarthritis |
9.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
9.5% |
| Crohn's Disease |
4.8% |
| Polyarthritis |
4.8% |
| Product Used For Unknown Indication |
4.8% |
| Prophylaxis Of Neural Tube Defect |
4.8% |
|
| Renal Failure Acute |
33.3% |
| Alveolitis |
16.7% |
| Oropharyngeal Pain |
16.7% |
| Pancytopenia |
16.7% |
| Premature Baby |
16.7% |
|
| Secondary |
| Crohn's Disease |
23.8% |
| Colitis Ulcerative |
18.5% |
| Rheumatoid Arthritis |
10.0% |
| Product Used For Unknown Indication |
8.5% |
| Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis |
7.7% |
| Erdheim-chester Disease |
5.4% |
| Hypertension |
4.6% |
| Drug Use For Unknown Indication |
3.1% |
| Granulomatosis With Polyangiitis |
3.1% |
| Breast Cancer |
2.3% |
| Coronary Artery Disease |
2.3% |
| Mesangioproliferative Glomerulonephritis |
1.5% |
| Myasthenia Gravis |
1.5% |
| Pemphigoid |
1.5% |
| Prophylaxis |
1.5% |
| Spondylitis |
1.5% |
| Cellulitis |
0.8% |
| Endoscopy |
0.8% |
| Gastrointestinal Disorder Therapy |
0.8% |
| Gout |
0.8% |
|
| Progressive Multifocal Leukoencephalopathy |
11.1% |
| Bursitis |
7.4% |
| Gastritis |
7.4% |
| Lymphoma |
7.4% |
| Malignant Melanoma |
7.4% |
| Squamous Cell Carcinoma |
7.4% |
| Colitis Ulcerative |
3.7% |
| Death |
3.7% |
| Febrile Neutropenia |
3.7% |
| Herpes Simplex |
3.7% |
| Herpes Virus Infection |
3.7% |
| Herpes Zoster |
3.7% |
| Large Intestinal Stenosis |
3.7% |
| Malaise |
3.7% |
| Pancytopenia |
3.7% |
| Plasma Cell Myeloma |
3.7% |
| Pneumonia Streptococcal |
3.7% |
| Positron Emission Tomogram Abnormal |
3.7% |
| Premature Labour |
3.7% |
| Pyelonephritis |
3.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.0% |
| Crohn's Disease |
33.6% |
| Rheumatoid Arthritis |
5.6% |
| Colitis Ulcerative |
5.0% |
| Drug Use For Unknown Indication |
4.8% |
| Immunosuppression |
2.5% |
| Renal Transplant |
2.3% |
| Granulomatosis With Polyangiitis |
1.3% |
| Pain |
1.3% |
| Autoimmune Hepatitis |
1.2% |
| Relapsing-remitting Multiple Sclerosis |
1.2% |
| Premedication |
1.0% |
| Hypertension |
0.8% |
| Osteoporosis |
0.8% |
| Prophylaxis |
0.8% |
| Immunoglobulin G4 Related Sclerosing Disease |
0.7% |
| Multiple Sclerosis |
0.7% |
| Chemotherapy |
0.5% |
| Hepatitis C |
0.5% |
| Idiopathic Thrombocytopenic Purpura |
0.5% |
|
| Pyrexia |
12.3% |
| Intestinal Stenosis |
11.1% |
| General Physical Health Deterioration |
8.6% |
| Ileus |
8.6% |
| Uterine Leiomyoma |
6.2% |
| Breast Cancer |
4.9% |
| Intestinal Resection |
4.9% |
| Pustular Psoriasis |
4.9% |
| Vomiting |
4.9% |
| Anorectal Disorder |
3.7% |
| Haematochezia |
3.7% |
| Pain In Extremity |
3.7% |
| Thrombosis |
3.7% |
| Wrong Technique In Drug Usage Process |
3.7% |
| Anal Fistula |
2.5% |
| B-lymphocyte Count Decreased |
2.5% |
| Biopsy Bone Marrow Abnormal |
2.5% |
| Circulatory Collapse |
2.5% |
| Crohn's Disease |
2.5% |
| Fatigue |
2.5% |
|
| Interacting |
|
| Drug Interaction |
85.7% |
| Mass |
14.3% |
|
